0.00
100.00%
-0.726
After Hours:
.76
0.76
+
Anew Medical Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Anew Medical Inc is a company with a primary focus on developing disruptive new therapies to alleviate and/or reverse the progression of neurodegenerative diseases through the use of cell and gene therapy.
See More
Previous Close:
$0.726
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$15.44M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
+0.00%
Anew Medical Inc Stock (WENA) Company Profile
Name
Anew Medical Inc
Sector
Industry
Phone
646-916-5315
Address
1115 BROADWAY, NEW YORK
Compare WENA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
WENA
Anew Medical Inc
|
0.00 | 15.44M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
482.28 | 124.20B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
697.05 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
651.30 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.00 | 34.95B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
117.14 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Anew Medical Inc Stock (WENA) Latest News
UP Manila is top performing medical school anew - MSN
Critical Comparison: Klotho Neurosciences (NASDAQ:KLTO) versus IN8bio (NASDAQ:INAB) - Defense World
AboitizPower's Therma Mobile recognized as Navotas City's top taxpayer anew - The Manila Times
Klotho Neurosciences, Inc. announced that it expects to receive $2 million in funding -January 22, 2025 - Marketscreener.com
Aboitiz Power’s Therma Mobile recognized as Navotas City’s top taxpayer anew - Malaya
PSEi down anew on Trump's first day in office - ABS-CBN.COM
Fontana shuttered anew over unpaid obligations - Inquirer.net
SGMO Pre-Market Shares Drop 40% Over Pfizer (PFE) Deal Collapse - Yahoo Finance
Huntington Bancshares (NASDAQ:HBANL) Stock Price Up 0% – What’s Next? - Defense World
Endeavour Mining (LON:EDV) Shares Down 0.6% – Time to Sell? - Defense World
HEICO (NYSE:HEI-A) Trading Up 1.2% – What’s Next? - Defense World
noco-noco (NASDAQ:NCNC) Stock Price Down 19.2% – Should You Sell? - Defense World
Head to Head Contrast: Klotho Neurosciences (NASDAQ:KLTO) & ImmunityBio (NASDAQ:IBRX) - Defense World
Padilla pushes for medical cannabis anew - ABS-CBN.COM
Daniel HaAnew Era TMS & Psychiatry, Psychiatrist, Austin, TX, 78746 - Psychology Today
C.H. Robinson speaks to investors – and Wall Street’s support soars anew - Yahoo Finance
Klotho Neurosciences, Inc. announced that it has received $1 million in funding from ACM Projektentwicklung GmbH - Marketscreener.com
Klotho Neurosciences, Inc. Appoints Dr. Merit Cudkowicz to Scientific Advisory Board - Marketscreener.com
PIRMA seeks anew to change form of gov't - ABS-CBN.COM
Safety Shot (NASDAQ:SHOT) Shares Up 3.3% – Here’s Why - Defense World
Nemus Bioscience (OTCMKTS:NMUS) Trading Down 9.5% – Here’s Why - Defense World
H-CYTE (OTCMKTS:HCYTD) Stock Price Down 49.5% – What’s Next? - Defense World
Duterte blasts Roxas' ally; slams 'oligarchs' anew - ABS-CBN.COM
Klotho Neurosciences expands Board with seasoned healthcare executive - Investing.com
PSEi nears 7,000 on dovish BSP stance - MSN
Klotho Neurosciences, Inc. and Teleost Biopharmaceuticals, LLC Terminate Licensing Agreement - Marketscreener.com
Klotho Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Controversial actor Bala bids adieu to Kochi to start anew with wife Kokila: ‘For a comfortable life, my family and my health’ - The Indian Express
Metro Pacific Expands Hospital Network with 27th Investment: General Trias Doctors - LionhearTV
KLTO stock touches 52-week low at $0.39 amid market challenges By Investing.com - Investing.com South Africa
KLTO stock touches 52-week low at $0.39 amid market challenges - Investing.com
Klotho Neurosciences CEO secures new three-year contract By Investing.com - Investing.com Australia
Klotho Neurosciences announces accounting firm change - Investing.com India
Klotho Neurosciences announces accounting firm change By Investing.com - Investing.com UK
Klotho Neurosciences CEO secures new three-year contract - Investing.com India
Klotho Neurosciences faces Nasdaq delisting over share price - Investing.com India
Klotho Neurosciences faces Nasdaq delisting over share price By Investing.com - Investing.com UK
Rowe Starts Anew by Leading Griffis Memorial Test at IMS - INDYCAR
KLTO stock touches 52-week low at $0.46 amid sharp annual decline - Investing.com UK
PhilHealth hikes dialysis package anew, now P1M a year - GMA News Online
Dr Randall McIntyreAnew Era TMS & Psychiatry, Psychiatrist, Houston, TX, 77080 - Psychology Today
KLTO Stock Plummets to 52-Week Low at $0.5 Amid Market Turbulence - Investing.com UK
Diesel and kerosene prices to be hiked anew Tuesday; no change for gasoline - GMA News Online
Dr Terry EaganAnew Era TMS & Psychiatry, Psychiatrist, Cedar Park, TX, 78613 - Psychology Today
Dr. Heather MakAnew Era TMS & Psychiatry, Psychiatrist, Huntington Beach, CA, 92647 - Psychology Today
Stephany LavigneAnew Era TMS & Psychiatry, Psychiatric Nurse Practitioner, Torrance, CA, 90503 - Psychology Today
Court OKs BJMP request for Alice Guo's medical checkup at hospital - GMA News Online
KLTO Stock Hits 52-Week Low at $0.72 Amid Market Challenges - Investing.com Canada
European stocks higher on Asian cheer; H&M discards key target - Investing.com
Morning Bid: Micron adds fresh tech fizz, China surges anew - Yahoo Finance
U.S. Global Investors (NASDAQ:GROW) Receives New Coverage from Analysts at StockNews.com - Defense World
Anew Medical Inc Stock (WENA) Financials Data
There is no financial data for Anew Medical Inc (WENA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):